Advertisement

Mechanismen der Thrombozytenhemmung durch PETN

  • A.-A. Weber
  • K. Schrör

Zusammenfassung

Die vasodilatierende Wirkung organischer Nitratester ist experimentell und klinisch gut belegt [1,19]. Für verschiedene Nitrate ist aber auch eine thrombozytenhemmende Wirkung nachgewiesen worden [3–5, 8].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ahlner J, Anderson RGG, Tofgard K, Axelsson KL (1991) Organic nitrate esters: clinical use and mechanisms of action. Pharmacol Rev 43: 351PubMedGoogle Scholar
  2. 2.
    BrüneB, Ullrich V (1987) Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32: 497Google Scholar
  3. 3.
    De Catering R, Giannessi D, Bernini W, Mazzone A (1988) Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Thromb Haemost 59: 207Google Scholar
  4. 4.
    Gerzer R, Karrenbrock B, Siess W, Heim J-M (1988) Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity. Thromb Res 52: 11PubMedCrossRefGoogle Scholar
  5. 5.
    Karlberg K-E, Tofgard K, Ahlner J, Sylvén C (1992) Dose-dependent effect of intravenous nitroglycerin on platelet aggregation and correlation with plasma glyceryl dinitrate concentration in healthy men. Am J Cardiol 69: 802PubMedCrossRefGoogle Scholar
  6. 6.
    Kojda G, Stein D, Kottenberg E, Schnaith EM, Noack E (1995) In vivo effects of pentaerithrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits. J Cardiovasc Pharmacol 25: 763PubMedCrossRefGoogle Scholar
  7. 7.
    Kuhn M, Otten A, Fröhlich JC, Förstermann U (1991) Glyceryl trinitrate increases platelet cGMP after metabolism in fibroblasts. Eur J Pharmacol 200: 175PubMedCrossRefGoogle Scholar
  8. 8.
    Loscalzo J (1985) N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest 76: 703PubMedCrossRefGoogle Scholar
  9. 9.
    Maurice DH, Haslam RJ (1990) Molecular basis of the synergistic inhibition of platelet function by nitro-vasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 37: 671PubMedGoogle Scholar
  10. 10.
    Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ (1981) Evidence for the inhibitory role of guanosine 3’, 5’-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946PubMedGoogle Scholar
  11. 11.
    Negrescu EV, Sazonova LN, Baldenkov GN, Mukharliamov NM, Mazaev AV, Tkachuk VA (1990) Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. Int J Cardiol 26: 175PubMedCrossRefGoogle Scholar
  12. 12.
    Nishikawa M, Kanamori M, Hidaka H (1982) Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and is metabolites. J Pharmacol Exp Ther 220: 183PubMedGoogle Scholar
  13. 13.
    Noack E, Kojda G (1994) Pentaerithrityltetranitrat. Gesichertes und Neues zur Pharmakologie eines Langzeitnitrats. Steinkopff-Verlag, DarmstadtGoogle Scholar
  14. 14.
    Salvemini D, Radziszewski R, Korbut R, Vane J (1990) The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO- donors. Br J Pharmacol 101: 991PubMedGoogle Scholar
  15. 15.
    Schrör K, Franta M, Weber A-A (1995) Wirkung von PETN auf Plättchenfunktion und cGMP-Bildung in Humanthrombozyten. In: Haustein K-O (Hrsg) Pentaerithrityltetranitrat. Pharmakologische Besonderheiten für Praxis und Klinik. Steinkopf Verlag, Darmstadt, p 5Google Scholar
  16. 16.
    Weber A-A, Strobach H, Schrör K (1993) Direct inhibition of platelet function by organic nitrates via nitric oxide formation. Eur J Pharmacol 247: 29PubMedCrossRefGoogle Scholar
  17. 17.
    Weber A-A, Franta M, Neuhaus T, Sachinidis A, Schrör K (1996) Effects of pentaerythritol tetranitrate on platelet function. Naunyn-Schmied Arch Pharmacol 353 (Suppl): R39Google Scholar
  18. 18.
    Weber A-A, Neuhaus T, Düsing R, Schrör K, Sachinidis A, Vetter H (1996) Biotransformation von Nitroglyzerin und Nitrattoleranz in gewaschenen Human-thrombozyten. Z Kardiol (im Druck)Google Scholar
  19. 19.
    Yusuf S, MacMahon S, Collins R, Peto R (1988) Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomized trials. Lancet 1: 1088PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, Darmstadt 1996

Authors and Affiliations

  • A.-A. Weber
  • K. Schrör

There are no affiliations available

Personalised recommendations